Dhruvalkumar Patel Acquires 10.01% Stake in Rekvina Laboratories

Dhruvalkumar Patel has disclosed a substantial acquisition of 11,12,562 equity shares, representing 10.01% of the total voting capital, in Rekvina Laboratories Limited. The acquisition was executed through a combination of a preferential allotment on August 12, 2026, and an open offer on August 13, 2026. The total consideration for the acquisition amounted to ₹3,01,40,000. Following this acquisition, Dhruvalkumar Patel's holding in Rekvina Laboratories now stands at 10.01%. This disclosure is made in compliance with SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.